Safety and feasibility of same‐day discharge following uncomplicated transvenous lead extraction

Introduction Transvenous lead extraction (TLE), while mostly a safe procedure, has risk of serious periprocedural complications. As such, overnight hospitalization remains a routine practice. In our center, we routinely discharge patients on the same day following an uncomplicated TLE. Methods This is a retrospective study of 265 consecutive patients who underwent uncomplicated TLE in our center between 2019 and 2021. Same‐day discharge (SDD) patients are compared with those who stayed at least overnight for observation after the TLE procedure (non‐SDD group). To assess the safety of an SDD strategy after uncomplicated TLE, the main study endpoint was to compare the rate of major procedure‐related complications at 1‐, 7‐, and 30‐days. To identify the factors influencing the operator's decision to discharge the patient on the same day, the secondary endpoint was to analyze clinical and procedural predictors of SDD. Results A total of 153 patients were discharged the same day after uncomplicated TLE (SDD), while 112 stayed at least overnight after the procedure (non‐SDD). There was no significant difference in major procedure‐related complications at 1‐day (SDD 0% vs. non‐SDD 1.8%, p value = ns), while patients in the SDD group had a lower rate of 7‐ and 30‐day complications when compared with those in the non‐SDD group (2.1% vs. 8.2%, p value = .0308; and 3.5% vs. 16%, p value = .0049, respectively). Noninfectious indication for TLE (OR 16.1, 95% confidence interval [CI] 4.29–77.6) and procedure end time before 12:00 (OR 2.82, 95% CI 1.11–7.27) were the only independent predictors of SDD. Conclusion SDD discharge following uncomplicated TLE in selected patients (i.e., those without device infection and when the TLE procedure is completed in the morning) is feasible and safe.